Services to Guide You
Choose your starting point within the product development life cycle to learn how we can support your team with immediate solutions on your path to healthcare access. Or choose a service category to view our full suite of services across Market Access, Medical Affairs, and Market Research solutions.
Pre-Clinical
Thinking strategically about your long-term goals before you’ve begun human trials can have large payoffs down the road. By engaging the right stakeholders and obtaining a thorough understanding of the landscape you can set your innovations up for success early on.
Medical Affairs and Education Solutions >
- Investigator and Scientific Advisory Boards
Market Research >
- Business Development Due Diligence
- Competitive Market Landscape Analysis
Phase 1
From the first dose in man or woman, it’s important to begin thinking about strategies that will ultimately support access for your innovative solutions when they are finally brought to market.
Medical Affairs and Education Solutions >
- Clinical Trial Recruitment Content Development
- Investigator and Scientific Advisory Boards
Market Research >
- Business Development Due Diligence
- Competitive Market Landscape Analysis
Phase 2
As your studies become larger and you seek to better understand dosing and efficacy, additional strategies need to be put into place to prepare you for your next stage of development, and eventual product launch.
Medical Affairs and Education Solutions >
- Clinical Trial Recruitment Content Development
- Competitive Brand Analysis
- Influencer/Key Opinion Leader (KOL) Identification and Mapping
- Investigator and Scientific Advisory Boards
- One-on-One Key Opinion Leader (KOL) Engagements
- Publication Strategy & Content Writing
- Scientific Platforms
Market Research >
- Budget Impact Analysis
- Business Development Due Diligence
- Competitive Market Landscape Analysis
- Product Value Proposition
Market and Payer Access >
- Healthcare Policy Research and Education
- Multi-Stakeholder Advisory Boards
- Value Proposition Message Development and Testing
Phase 3
In this final phase of development before launch, having a broad strategy to ensure access will be a key to your future success. As you approach regulatory filing and likely approval, there are many pieces that must be put into place to support future success.
Medical Affairs and Education Solutions >
- Advocacy Strategy and Engagement
- Clinical Compendia and Pathways Submissions
- Clinical Trial Recruitment Content Development
- Competitive Brand Analysis
- Influencer/Key Opinion Leader (KOL) Identification and Mapping
- Investigator and Scientific Advisory Boards
- Launch Materials Medical Writing
- One-on-One Key Opinion Leader (KOL) Engagements
- Publication Strategy & Content Writing
- Sales and MSLs Training Materials
- Scientific Platforms
Market Research >
- Budget Impact Analysis
- Business Development Due Diligence
- Clinical Pathway Landscape Mapping
- EU Payment Systems Research
- Treatment Landscape Benchmarking & Analysis
- US Payer Landscape Analysis
- Workforce Benchmarking
Market and Payer Access >
- Clinical Compendia and Pathways Strategies
- Coding Reimbursement Strategy
- Electronic Medical Record (EMR) Vendor Engagement Strategy
- Healthcare Policy Research and Education
- Multi-Stakeholder Advisory Boards
- Payer Strategy & Engagement
- Pricing Strategy and Research
- Value Proposition Message Development and Testing
Regulatory Review
This fast-moving time between regulatory filing and approval is ripe with strategic decisions which can support access to your innovations. Whether you have been assigned a standard PDUFA date, accelerated approval, fast-track designation, priority review, or breakthrough therapy designation, critical decisions during this timeframe will set the stage for your future success.
Medical Affairs and Education Solutions >
- Advocacy Strategy and Engagement
- Clinical Compendia and Pathways Submissions
- Investigator and Scientific Advisory Boards
- Launch Materials Medical Writing
- One-on-One Key Opinion Leader (KOL) Engagements
- Publication Strategy & Content Writing
- Sales and MSLs Training Materials
- Scientific Platforms
Market Research >
- Budget Impact Analysis
- Clinical Pathway Landscape Mapping
- EU Payment Systems Research
- Treatment Landscape Benchmarking & Analysis
- US Payer Landscape Analysis
- Workforce Benchmarking
Market and Payer Access >
- Clinical Compendia and Pathways Strategies
- Coding Reimbursement Strategy
- Electronic Medical Record (EMR) Vendor Engagement Strategy
- Healthcare Policy Research and Education
- Multi-Stakeholder Advisory Boards
- Payer Strategy & Engagement
- Pricing Strategy and Research
- Value Proposition Message Development and Testing
Post Approval & Marketing
Just because your product has been approved does not mean your work is done. Whether you are anticipating incremental data releases, seeking approval in supplemental indications, filing for approval in additional markets, or facing previously unforeseen barriers to access, it is important to have a clear strategy to support the development and implementation of strategic solutions.
Medical Affairs and Education Solutions >
- Advocacy Strategy and Engagement
- Clinical Compendia and Pathways Submissions
- Compendia and Pathways Maintenance Strategies
- Investigator and Scientific Advisory Boards
- One-on-One Key Opinion Leader (KOL) Engagements
- Publication Strategy & Content Writing
- Scientific Platforms
Market Research >
- Clinical Pathway Landscape Mapping
- EU Payment Systems Research
- Product Value Proposition
- Pulse Surveys: Field Team Evaluation
- Treatment Landscape Benchmarking & Analysis
- US Payer Landscape Analysis
Market and Payer Access >
- Clinical Compendia and Pathways Strategies
- Coding Reimbursement Strategy
- Electronic Medical Record (EMR) Vendor Engagement Strategy
- Healthcare Policy Research and Education
- Multi-Stakeholder Advisory Boards
- Payer Coverage, Compendia, and Pathways Monitoring
- Payer Strategy & Engagement
